JUPITER-02 Final Overall Survival Analysis in Intent-To-Treat Population

Coherus-Final OS Toripalimab Figure 2 ASCO 2023

Presented at ASCO 2023

Format

PNG

Source

Coherus BioSciences, Inc.

Téléchargements